248 related articles for article (PubMed ID: 21737126)
1. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
[TBL] [Abstract][Full Text] [Related]
3. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay.
Hellum M; Øvstebø R; Trøseid AM; Berg JP; Brandtzaeg P; Henriksson CE
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):520-6. PubMed ID: 22732249
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
5. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
6. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
7. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
8. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters.
Vila-Liante V; Sánchez-López V; Martínez-Sales V; Ramón-Nuñez LA; Arellano-Orden E; Cano-Ruiz A; Rodríguez-Martorell FJ; Gao L; Otero-Candelera R
Clin Chem Lab Med; 2016 Nov; 54(11):1759-1767. PubMed ID: 27155005
[TBL] [Abstract][Full Text] [Related]
9. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
10. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
[TBL] [Abstract][Full Text] [Related]
11. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
[TBL] [Abstract][Full Text] [Related]
12. Pre-analytical and analytical issues in the analysis of blood microparticles.
Yuana Y; Bertina RM; Osanto S
Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
[TBL] [Abstract][Full Text] [Related]
13. Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
Yuana Y; Osanto S; Bertina RM
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):244-50. PubMed ID: 22343682
[TBL] [Abstract][Full Text] [Related]
14. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy.
Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC
J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407
[TBL] [Abstract][Full Text] [Related]
15. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.
Aleman MM; Gardiner C; Harrison P; Wolberg AS
J Thromb Haemost; 2011 Nov; 9(11):2251-61. PubMed ID: 21883880
[TBL] [Abstract][Full Text] [Related]
16. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
Christersson C; Lindahl B; Siegbahn A
Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
[TBL] [Abstract][Full Text] [Related]
17. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
19. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools?
Vieira LM; Dusse LM; Fernandes AP; Martins-Filho OA; de Bastos M; Ferreira MF; Cooper AJ; Lwaleed BA; Carvalho MG
Thromb Res; 2007; 119(2):157-65. PubMed ID: 16527335
[TBL] [Abstract][Full Text] [Related]
20. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
